REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 53 filers reported holding REGULUS THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,000 | -98.9% | 572 | -98.5% | 0.00% | – |
| Q4 2016 | $88,000 | +14.3% | 39,039 | +68.2% | 0.00% | – |
| Q3 2016 | $77,000 | +87.8% | 23,212 | +62.1% | 0.00% | – |
| Q2 2016 | $41,000 | -82.1% | 14,322 | -56.7% | 0.00% | – |
| Q1 2016 | $229,000 | +116.0% | 33,051 | +169.8% | 0.00% | – |
| Q4 2015 | $106,000 | +12.8% | 12,249 | -14.4% | 0.00% | – |
| Q3 2015 | $94,000 | -59.7% | 14,315 | -32.4% | 0.00% | – |
| Q2 2015 | $233,000 | -34.7% | 21,175 | +0.4% | 0.00% | – |
| Q1 2015 | $357,000 | -0.3% | 21,094 | -5.6% | 0.00% | – |
| Q4 2014 | $358,000 | +8850.0% | 22,342 | +3133.3% | 0.00% | – |
| Q3 2014 | $4,000 | +300.0% | 691 | +390.1% | 0.00% | – |
| Q2 2014 | $1,000 | -97.8% | 141 | -97.2% | 0.00% | – |
| Q1 2014 | $46,000 | 0.0% | 5,116 | -17.8% | 0.00% | – |
| Q4 2013 | $46,000 | – | 6,221 | +14711.9% | 0.00% | – |
| Q3 2013 | $0 | – | 42 | +250.0% | 0.00% | – |
| Q2 2013 | $0 | – | 12 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |